Zhenyu Dai

Development and functional characterization of novel fully human anti‐CD19 chimeric antigen receptors for T‐cell therapy

Jianfeng Zhou, G. Hu, Xuelian Hu, 2021, Journal of cellular physiology.

T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape

Jiali Cheng, Chaohong Liu, Jianfeng Zhou, 2022, Signal Transduction and Targeted Therapy.

Preclinical evaluation of MRG002, a novel HER2-targeting antibody-drug conjugate with potent antitumor activity against HER2-positive solid tumors.

Hongfeng Li, Zhenyi Xu, Hu Li, 2021, Antibody therapeutics.

The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains

Jianfeng Zhou, Q. Wei, W. Mu, 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia

Dengju Li, Jing Zhou, Haolong Lin, 2020, Cancer medicine.

B7H6 Serves as a Negative Prognostic Marker and an Immune Modulator in Human Pancreatic Cancer

Xing Wu, Songbing He, K. Teng, 2022, Frontiers in Oncology.

Preclinical development and evaluation of nanobody-based CD70-specific CAR T cells for the treatment of acute myeloid leukemia

Jiali Cheng, Liang Huang, Jue Wang, 2023, Cancer Immunology, Immunotherapy.